top of page

Seamus Jiang, MBA

President, Board Member, BioKatalyst

Managing Director of China/US  Cross-boarder deals leader, PwC US

Seamus Jiang is the 2022-2023 President of BioKatalyst.  He lives in Philadelphia suburbs with wife (also in the pharma industry) and two kids (10 & 6). 


Seamus has been an active contributor to BioKatalyst in the last 3 years including organizing biotech-focused events benefiting members and member startups and connecting them with mainstream players.  In particular, he was one of the key organizers for various COVID-19 relief/donation activities last year.  Seamus has extensive relationship with the biotech investing communities including various US/China mainstream PE/VCs and pharmaceutical companies.  He has deep relationship with industry organizations such as SAPA, CBA, CABS and BayHelix and is a regular speaker at various cross-border business and life sciences conferences. 


Seamus is a Managing Director of PwC US with over 20 years of M&A and finance experience in North America and Asia.  He has been assisting strategic and financial buyers/sellers in evaluating over 300 M&A and investment transactions with an aggregate deal value of over $190 billion, including many projects in Pharma, Life Sciences and Healthcare sectors. He leads PwC US’ US/Asia Cross-border Deals practice with over 80 Asia/US cross-border M&A and investment projects and is a leader of PwC US’s China Business Network. Previously, Seamus worked at GE Capital and PwC China. 


Seamus earned a B.A. in Economics from Fudan and an MBA from Emory University. He is a CFA charterholder and holds CPA licenses in both U.S. and China. Seamus holds leadership roles at diversity and inclusion organizations including Ascend, ACG and PwC’s Pan Asian Community Inclusion Network.

bottom of page